Deborah Marriott
Impact in
- Parasitology top 0.1%
- Parasitic Infections and Diagnostics
- Infectious Diseases top 0.2%
- Antifungal resistance and susceptibility
- Amoebic Infections and Treatments
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antifungal resistance and susceptibility 36
- Amoebic Infections and Treatments 27
- Antimicrobial Resistance in Staphylococcus 13
- Epidemiology 44
- Fungal Infections and Studies 21
- Pneumocystis jirovecii pneumonia detection and treatment 16
- Co-authors
- Damien Stark (35 shared papers)John Ellis (31 shared papers)J. Harkness (21 shared papers)Tania C. Sorrell (17 shared papers)John Harkness (18 shared papers)Joel Barratt (17 shared papers)David Ellis (7 shared papers)Andrew Field (9 shared papers)
- Journals
- Journal of Clinical Microbiology (12 papers)Therapeutic Drug Monitoring (10 papers)The Medical Journal of Australia (8 papers)Clinical Infectious Diseases (7 papers)Emerging infectious diseases (6 papers)
- Partner nations
- AustraliaUnited StatesItaly
In The Last Decade
Deborah Marriott
146 papers receiving 6.7k citations
Deborah Marriott's Hit Papers
Peers
Comparison fields: 5 of 130
- Parasitology 1.8k
- Infectious Diseases 3.8k
- Applied Microbiology and Biotechnology 207
- Epidemiology 2.4k
- Pharmacology 974
Countries citing papers authored by Deborah Marriott
This map shows the geographic impact of Deborah Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Marriott more than expected).
Fields of papers citing papers by Deborah Marriott
This network shows the impact of papers produced by Deborah Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Marriott. The network helps show where Deborah Marriott may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Marriott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# Hit paper breakdown → | 2020 | 673 |
| 2 | 2000 | 355 | |
| 3 | 1998 | 221 | |
| 4 | 2016 | 167 | |
| 5 | 1992 | 164 | |
| 6 | 2009 | 151 | |
| 7 | 2006 | 146 | |
| 8 | 2006 | 141 | |
| 9 | 2012 | 141 | |
| 10 | 2009 | 134 | |
| 11 | 2012 | 117 | |
| 12 | 2008 | 114 | |
| 13 | 2019 | 103 | |
| 14 | 2010 | 103 | |
| 15 | 2011 | 102 | |
| 16 | 2010 | 101 | |
| 17 | 2007 | 100 | |
| 18 | 2007 | 90 | |
| 19 | 2013 | 90 | |
| 20 | 2014 | 88 |
About Deborah Marriott
Deborah Marriott is a scholar working on Infectious Diseases, Epidemiology, Parasitology, Pharmacology and Endocrinology, having authored 150 papers that have together received 6.9k indexed citations. Recurring topics across this work include Parasitic Infections and Diagnostics (40 papers), Antifungal resistance and susceptibility (36 papers), Amoebic Infections and Treatments (27 papers), Fungal Infections and Studies (21 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Legionella and Acanthamoeba research (8 papers). The work is most often cited by research in Parasitology (1.8k citations), Infectious Diseases (3.8k citations), Applied Microbiology and Biotechnology (207 citations), Epidemiology (2.4k citations) and Pharmacology (974 citations). Deborah Marriott has collaborated with scholars based in Australia, United States and Italy. Frequent co-authors include Damien Stark, John Ellis, J. Harkness, Tania C. Sorrell, John Harkness, Joel Barratt, David Ellis, Andrew Field, Monica A. Slavin and John E. Ray. Their work appears in journals such as Journal of Clinical Microbiology, Therapeutic Drug Monitoring, The Medical Journal of Australia, Clinical Infectious Diseases and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.